Types segmentation classifies outsourced pathology activities by the technical methodology employed, each contributing distinct revenue streams within the Pathology Outsourcing Services market. Histopathology services, encompassing tissue fixation, embedding, sectioning and staining, generate the bulk of outsourced volume, roughly 40 % of market value, because they are essential for routine cancer diagnosis and chronic disease monitoring. Cytology outsourcing, accounting for about 20 %, includes preparation of fine‑needle aspirates, Pap smears and body‑fluid examinations, where external labs provide specialized slide‑reading expertise and quality assurance. Molecular pathology—covering PCR, next‑generation sequencing and in‑situ hybridization—commands an estimated 25 % share, driven by personalized‑medicine initiatives that require high‑throughput, validated assays. Digital pathology services, representing near 10 % of the market, involve whole‑slide imaging, AI‑assisted interpretation and secure cloud storage, enabling remote review and workflow integration. Finally, autopsy and forensic pathology outsourcing, though a smaller niche at 5 %, supplies legal and research institutions with comprehensive post‑mortem examinations. Together, these type categories delineate the market taxonomy and illustrate how methodological diversity underpins overall market growth.